Important: This page is general information, not medical advice. It does not recommend or prescribe any treatment. Always consult your doctor or pharmacist before starting, stopping or changing any medicine.
About Melanoma
Melanoma is the most serious type of skin cancer. Often the first sign of melanoma is a change in the size, shape, color, or feel of a mole. Most melanomas have a black or black-blue area. Melanoma may also appear as a new mole. It may be black, abnormal, or "ugly looking."
Thinking of "ABCDE" can help you remember what to watch for:
- Asymmetry - the shape of one half does not match the other
- Border - the edges are ragged, blurred or irregular
- Color - the color is uneven and may include shades of black, brown and tan
- Diameter - there is a change in size, usually an increase
- Evolving - the mole has changed over the past few weeks or months
Surgery is the first treatment of all stages of melanoma. Other treatments include chemotherapy and radiation, biologic, and targeted therapies. Biologic therapy boosts your body's own ability to fight cancer. Targeted therapy uses substances that attack cancer cells without harming normal cells.
It sits within Cancers and Skin, Hair and Nails.
The lead U.S. institute for this subject is the National Cancer Institute.
When to speak to someone. Reading about a topic cannot tell you whether it applies to you. Speak to a doctor or pharmacist if symptoms are severe, sudden, getting worse, or simply not going away — and seek emergency care immediately for chest pain, breathing difficulty, sudden weakness or confusion, or a serious allergic reaction.
Research on Melanoma
3,737 studies areregistered for this condition on ClinicalTrials.gov, the U.S. National Library of Medicine's public registry. A selection is below — the links go straight to the registry entry, not to a summary of ours.
What a registered study does and does not mean. Registration means a study exists and has been declared publicly. It says nothing about whether the treatment being tested works, is safe, or is available to you. Many studies find no benefit — that is what research is for. Never seek out an experimental treatment on the strength of a registry entry alone.
Research currently under way
- Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)National Cancer Institute (NCI)
- Physician/Patient Choice of Either High-Dose Recombinant Interferon Alfa-2B or Ipilimumab, Versus Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by SurgeryNational Cancer Institute (NCI)
- Sitagliptin With Pembro in RCC and MelanomaFernando Maciel Barbosa
- Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer SurvivorsUniversity of Southern California
- Phase I, Open-Label, Study of Tumor Infiltrating Lymphocytes Engineered With Membrane Bound IL15 Plus Acetazolamide in Adult Patients With Metastatic MelanomaM.D. Anderson Cancer Center
- Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic CancerAulos Bioscience, Inc.
Research already completed
- Burosumab for CSHSLaura Tosi
- Study of HBI-8000 With Nivolumab in Melanoma, Renal Cell Carcinoma and Non-Small Cell Lung CancerHUYABIO International, LLC.
Study data from ClinicalTrials.gov, a service of the U.S. National Library of Medicine. Retrieved 2026-07-30. Registry entries are supplied by study sponsors and investigators; ClinicalTrials.gov does not verify their scientific validity. PocketsInfo is not affiliated with, and not endorsed by, the NLM or the NIH.
Where to read more
Rather than paraphrase, we point you to the primary sources. Every link below is to a government health agency, a national institute or a recognised medical body — grouped by what you are trying to find out.
Start Here
- General Information about MelanomaNational Cancer Institute
- MelanomaAmerican Academy of Dermatology
Diagnosis and Tests
- BRAF Genetic TestNational Library of Medicine
- LymphoscintigraphyRadiological Society of North America
- PDL1 (Immunotherapy) TestsNational Library of Medicine
- Sentinel Lymph Node BiopsyNational Library of Medicine
- Skin BiopsyVisualDX
- Skin Cancer ScreeningNational Cancer Institute
- Skin Cancer ScreeningNational Library of Medicine
Treatments and Therapies
- Drugs Approved for MelanomaNational Cancer Institute
Prevention and Risk Factors
- Common Moles, Dysplastic Nevi, and Risk of MelanomaNational Cancer Institute
- Detect Skin Cancer: Body Mole MapAmerican Academy of Dermatology
- Risk Factors for Melanoma Skin CancerAmerican Cancer Society
- Skin Cancer PreventionNational Cancer Institute
Living With
- Living as a Melanoma Skin Cancer SurvivorAmerican Cancer Society
Related Issues
- Moles: OverviewAmerican Academy of Dermatology
- Related Conditions (Parkinson's Disease)Parkinson's Foundation
Genetics
- Giant congenital melanocytic nevus: MedlinePlus GeneticsNational Library of Medicine
- Melanoma: MedlinePlus GeneticsNational Library of Medicine
Statistics and Research
- Advances in Melanoma and Other Skin Cancers ResearchNational Cancer Institute
- Cancer Stat Facts: Melanoma of the SkinNational Cancer Institute
- Melanoma of the Skin StatisticsCenters for Disease Control and Prevention
Clinical Trials
- ClinicalTrials.gov: Intraocular (Eye) MelanomaNational Institutes of Health
- ClinicalTrials.gov: MelanomaNational Institutes of Health
Medical subject headings
Clinicians and researchers index this subject under Melanoma. These are the terms to use when searching medical literature.
This page is built from the MedlinePlus health topic record for Melanoma, a service of the U.S. National Library of Medicine (NLM), National Institutes of Health. Information is from MedlinePlus.gov. PocketsInfo is not affiliated with, and is not endorsed by, the NLM or the NIH. Retrieved 30 July 2026.